Full-Time

Executive Director

Financial Planning & Analysis, Commercial

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Expected to be in the office 70% of the time with flexibility to work from home up to 30%.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Financial analysis
Requirements
  • 12+ years of progressive leadership experience in financial planning & analysis, financial operations, or related fields.
  • Bachelor’s degree required.
  • Global experience working cross-functionally within commercial and revenue-focused functions, such as brand marketing, commercial operations, and sales.
  • Demonstrated experience in a matrixed, global organization with a track record of leading revenue forecasting and portfolio management initiatives.
  • MBA and/or CPA preferred.
  • Pharmaceutical or biotechnology industry experience.
Responsibilities
  • Lead the financial planning and analysis activities for revenue forecasting and scenario planning, working closely with the CCO and SVP, Commercial Finance, to ensure the accuracy and reliability of revenue projections used in external and internal reporting.
  • Oversee and consolidate annual budgets, quarterly forecasts, and long-term revenue plans, ensuring timely and effective revenue management aligned with corporate growth objectives.
  • Engage in capital allocation and portfolio management within the Commercial function, playing a key role with the Commercial Leadership Team (CLT) in assessing portfolio progress and ensuring efficient allocation of the ~$500M commercial opex budget to maximize value and support growth initiatives.
  • Build and maintain strong relationships with the Commercial functional leaders to understand their revenue-focused financial needs and provide proactive support, fostering a collaborative environment for clear communication and effective decision-making.
  • Act as a trusted advisor, offering financial guidance and recommendations to drive revenue performance and achieve strategic objectives for the commercial organization.
  • Develop and lead comprehensive revenue forecasting and analysis, focusing on operating and capital expenses, key trends, and variance analysis to support decision-making across commercial functions.
  • Manage capital allocation processes and conduct scenario analysis for the Commercial spend profile, optimizing resources and enhancing strategic alignment with corporate goals.
  • Oversee the Poland MESH Finance team to drive process excellence, standardization, and efficiency improvements across FP&A activities, gaining traction in areas that promote consistency and streamlined processes within the global finance organization.
  • Present financial results and insights to senior management, including the CEO, CFO, and Commercial leadership, effectively communicating complex financial information and strategic recommendations.
  • Lead and mentor a high-performing team of finance professionals, fostering a collaborative culture of continuous improvement and encouraging bold, innovative approaches to both professional and personal growth.
  • Provide coaching and development opportunities to enhance the skills and capabilities of team members, building a finance team that exemplifies a relentless pursuit of excellence.
  • Promote a positive and inclusive work environment that encourages innovation and curiosity, supporting a culture that values learning and growth.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?